| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ACELYRIN, Inc. | Director | Common Stock | 3K | $20.6K | $6.86 | Jul 17, 2024 | Direct |
| ACELYRIN, Inc. | Director | Director Stock Option (right to buy) | 92.2K | Jun 7, 2024 | Direct | ||
| Day One Biopharmaceuticals, Inc. | Director | Director Stock Option (Right to buy Common Stock) | 37.5K | Jun 22, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SLRN | ACELYRIN, Inc. | Jul 17, 2024 | 1 | -$7 | 4 | Jul 19, 2024 | Director |
| SLRN | ACELYRIN, Inc. | Jun 7, 2024 | 1 | $0 | 4 | Jun 11, 2024 | Director |
| DAWN | Day One Biopharmaceuticals, Inc. | Jun 22, 2023 | 1 | $0 | 4 | Jun 26, 2023 | Director |
| SLRN | ACELYRIN, Inc. | May 9, 2023 | 3 | $54K | 4 | May 11, 2023 | Director |
| SLRN | ACELYRIN, Inc. | May 4, 2023 | 1 | $0 | 4 | May 4, 2023 | Director |
| SLRN | ACELYRIN, Inc. | May 4, 2023 | 0 | $0 | 3 | May 4, 2023 | Director |
| DAWN | Day One Biopharmaceuticals, Inc. | Jun 21, 2022 | 1 | $0 | 4 | Jun 23, 2022 | Director |
| DAWN | Day One Biopharmaceuticals, Inc. | Jun 1, 2021 | 2 | $80K | 4 | Jun 1, 2021 | Director |
| DAWN | Day One Biopharmaceuticals, Inc. | May 26, 2021 | 0 | $0 | 3 | May 26, 2021 | Director |